Whole gut lavage fluid interleukin-1beta and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remission (Q44073510)

29 November 2017

title

Whole gut lavage fluid interleukin-1beta and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remission (English)

1 reference

29 November 2017

0 references

1 reference

I D R Arnott

1

1 reference

29 November 2017

N Williams

series ordinal

2

1 reference

29 November 2017

H E Drummond

series ordinal

3

1 reference

29 November 2017

S Ghosh

series ordinal

4

1 reference

29 November 2017

publication date

1 June 2002

1 reference

Digestive and Liver Disease

29 November 2017

published in

1 reference

29 November 2017

volume

34

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

424-429

1 reference

Inflammatory bowel disease and tobacco smoke--a case-control study

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Smoking habits and recurrence in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Smoking is a predictive factor for outcome after colectomy and ileorectal anastomosis in patients with Crohn's colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Smoking cessation and the course of Crohn's disease: an intervention study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Abnormal intestinal permeability predicts relapse in inactive Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Classification of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980040-8

7 January 2021

10.1016/S1590-8658(02)80040-8

Identifiers

DOI

1 reference

29 November 2017

1 reference